Unknown

Dataset Information

0

Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma.


ABSTRACT: We developed a nanovector with double targeting properties for efficiently delivering the tumor suppressor gene RASSF1A specifically into hepatocellular carcinoma (HCC) cells by preparing galactosylated-carboxymethyl chitosan-magnetic iron oxide nanoparticles (Gal-CMCS-Fe3O4-NPs). After conjugating galactose and CMCS to the surface of Fe3O4-NPs, we observed that Gal-CMCS-Fe3O4-NPs were round with a relatively stable zeta potential of +6.5 mV and an mean hydrodynamic size of 40.1 ± 5.3 nm. Gal-CMCS-Fe3O4-NPs had strong DNA condensing power in pH 7 solution and were largely nontoxic. In vitro experiments demonstrated that Gal-CMCS-Fe3O4-NPs were highly selective for HCC cells and liver cells. In vivo experiments showed the specific accumulation of Gal-CMCS-Fe3O4-NPs in HCC tissue, especially with the aid of an external magnetic field. Nude mice with orthotopically transplanted HCC received an intravenous injection of the Gal-CMCS-Fe3O4-NPs/pcDNA3.1(+)RASSF1A compound and intraperitoneal injection of mitomycin and had an external magnetic field applied to the tumor area. These mice had the smallest tumors, largest percentage of TUNEL-positive cells, and highest caspase-3 expression levels in tumor tissue compared to other groups of treated mice. These results suggest the potential application of Gal-CMCS-Fe3O4-NPs for RASSF1A gene delivery for the treatment of HCC.

SUBMITTER: Xue WJ 

PROVIDER: S-EPMC4768135 | BioStudies | 2016-01-01

SECONDARY ACCESSION(S): 10.1038/srep22149

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5358985 | BioStudies
2018-01-01 | S-EPMC5743840 | BioStudies
2015-01-01 | S-EPMC4658053 | BioStudies
1000-01-01 | S-EPMC4063981 | BioStudies
1000-01-01 | S-EPMC3299599 | BioStudies
2020-01-01 | S-EPMC7070039 | BioStudies
1000-01-01 | S-EPMC6305692 | BioStudies
2018-01-01 | S-EPMC5865143 | BioStudies
1000-01-01 | S-EPMC5577113 | BioStudies
2020-01-01 | S-EPMC7330025 | BioStudies